Abiratas 500mg Abiraterone Acetate Tablet

Trade Name: Abiraterone

Manufacturer: Intas Pharmaceuticals Ltd

Presentation: Tablet

Strength: 500mg

 

Can you stay on abiraterone acetate for a long time?

abiraterone acetate acid derivation has been displayed in preliminaries to increment the future. In the larger research, around 50 out of 100 men who received conventional treatment were still living after three years, while 70 out of 100 men who received Abiratas treatment were still alive after three years.

What is your strategy for dealing with abiraterone acetate?

  • As instructed by your doctor, take this medication once daily on an empty stomach (at least 1 hour before or 2 hours after food).
  • When you take abiraterone with food, the amount of the drug in your body increases dramatically, increasing the risk of negative effects.
  • Completely swallow the tablets.

Read more

When do I start taking Abiratas ?

Abiraterone acetate is a tablet that is taken orally. It is administered once a day. It must be consumed on an empty stomach [two hours after or one hour before a meal]. It should be taken every day at around the same time.

What is the purpose of the medicine abiraterone?

Abiraterone is a medication that is used in conjunction with prednisone to treat prostate cancer that has progressed to other regions of the body. Abiraterone has a place with the class of medications known as androgen biosynthesis inhibitors. It works by bringing down the body’s degrees of explicit chemicals.

Is abiraterone used to treat cancer?

Zytiga (abiraterone acetic acid derivation) is a chemical medicine that is utilized related to prednisone to treat men who have a prostate disease that has advanced to different pieces of their bodies (metastasized). Zytiga isn’t a sort of chemotherapy, regardless of the way that treating cancer is utilized.

How quickly does abiraterone start working?

Abiraterone also increased the median time until cancer progressed from 14.8 months to 33 months in phase III clinical trial of 1,200 men. The data will be discussed in a press conference today and presented at the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO).

We are a Global Wholesaler and Exporter from India and work in more than 5 countries like UAE, Saudi, Oman, Qatar, and Myanmar. moving beyond you are searching for another product or brand click here.